![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men | PLOS ONE
![Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer](https://www.mdpi.com/cells/cells-09-02116/article_deploy/html/images/cells-09-02116-g001.png)
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/adf2d3f5-f120-4033-88a6-3fc175a7a0aa/gr1.jpg)
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://www.mdpi.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001.png)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Screenshots of the Rotterdam Prostate Cancer Risk app. (SWOP. (2019).... | Download Scientific Diagram Screenshots of the Rotterdam Prostate Cancer Risk app. (SWOP. (2019).... | Download Scientific Diagram](https://www.researchgate.net/publication/336375990/figure/fig4/AS:960080837111810@1605912517639/Screenshots-of-the-Rotterdam-Prostate-Cancer-Risk-app-SWOP-2019-Rotterdam-Prostate.png)
Screenshots of the Rotterdam Prostate Cancer Risk app. (SWOP. (2019).... | Download Scientific Diagram
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![Personalizing Prostate Cancer Diagnosis with Multivariate Risk Prediction Tools: How Should Prostate MRI Be Incorporated? - Beyond the Abstract Personalizing Prostate Cancer Diagnosis with Multivariate Risk Prediction Tools: How Should Prostate MRI Be Incorporated? - Beyond the Abstract](https://www.urotoday.com/images/PI_RADS_matrix.png)